Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Rajewski

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Current Alzheimer Research|July 18, 2006
Ongoing in vivo studies with cytoskeletal drugs in tau transgenic miceMary L Michaelis, G Georg, H Telikepalli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 26, 2000
Stability of rifabutin in two extemporaneously compounded oral liquidsJ L Haslam, K L Egodage, Y Chen, et al.
Pharmaceutical Research|February 1, 1996
The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrinsK Okimoto, R A Rajewski, K Uekama, et al.
Journal of Pharmaceutical Sciences|February 1, 1997
Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroidsV Zia, R A Rajewski, E R Bornancini, et al.
Journal of Pharmaceutical Sciences|August 1, 1995
Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivativesR A Rajewski, G Traiger, J Bresnahan, et al.
Carbohydrate Research|April 21, 1997
Fractionation and characterization of 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, E R Bornancini, D O Thompson, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1995
Stereo-specific analysis of a novel protein kinase C inhibitorR A Rajewski, D G Kosednar, T A Matches, et al.
Pharmaceutical Research|October 30, 1998
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CDK Okimoto, M Miyake, N Ohnishi, et al.
Carbohydrate Research|April 21, 1997
Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, D G Vander Velde, R J Tait, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 1999
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agentK Okimoto, A Ohike, R Ibuki, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Current Alzheimer Research|July 18, 2006
Ongoing in vivo studies with cytoskeletal drugs in tau transgenic miceMary L Michaelis, G Georg, H Telikepalli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 26, 2000
Stability of rifabutin in two extemporaneously compounded oral liquidsJ L Haslam, K L Egodage, Y Chen, et al.
Pharmaceutical Research|February 1, 1996
The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrinsK Okimoto, R A Rajewski, K Uekama, et al.
Journal of Pharmaceutical Sciences|February 1, 1997
Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroidsV Zia, R A Rajewski, E R Bornancini, et al.
Journal of Pharmaceutical Sciences|August 1, 1995
Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivativesR A Rajewski, G Traiger, J Bresnahan, et al.
Carbohydrate Research|April 21, 1997
Fractionation and characterization of 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, E R Bornancini, D O Thompson, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1995
Stereo-specific analysis of a novel protein kinase C inhibitorR A Rajewski, D G Kosednar, T A Matches, et al.
Pharmaceutical Research|October 30, 1998
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CDK Okimoto, M Miyake, N Ohnishi, et al.
Carbohydrate Research|April 21, 1997
Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, D G Vander Velde, R J Tait, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 1999
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agentK Okimoto, A Ohike, R Ibuki, et al.
Pageof 3